These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 26536708)
1. [The expression and clinical significance of EphA2 and E-cadherin in papillary thyroid carcinoma]. Liu Y; Miao Y; Li X Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Jun; 29(11):1020-3. PubMed ID: 26536708 [TBL] [Abstract][Full Text] [Related]
2. [Expression and significance of serum E-cadherin in patients with papillary thyroid carcinoma]. Sun L; Wang DM; Zhang WJ; Zhang J; Wu JF Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jan; 31(2):123-126. PubMed ID: 29871201 [No Abstract] [Full Text] [Related]
4. [The study of the correlation of papillary thyroid carcinoma's invasion toward Ezrin and E-cadherin]. Liu C; Chen X; Gao Z; Liu Z; Tao X Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Sep; 26(17):789-91, 795. PubMed ID: 23214316 [TBL] [Abstract][Full Text] [Related]
5. [Relationship between activated STAT3 protein and epithelial-mesenchymal transition in papillary thyroid carcinoma]. Zhang Z; Bai Y; Li P; Zhao J; Wang Y; Sun L; Tang J Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Nov; 27(22):1265-8. PubMed ID: 24616987 [TBL] [Abstract][Full Text] [Related]
6. Co-expression and clinical utility of Snail and N-cadherin in papillary thyroid carcinoma. Yang X; Shi R; Zhang J Tumour Biol; 2016 Jan; 37(1):413-7. PubMed ID: 26219900 [TBL] [Abstract][Full Text] [Related]
7. [Expression of EpCAM and E-cadherin in papillary thyroid carcinoma and its clinicopathologic significance]. Cheng Y; Meng Y; Liang Z; Yang C; Luo Y; Cui Q Zhonghua Bing Li Xue Za Zhi; 2015 Mar; 44(3):189-94. PubMed ID: 26268754 [TBL] [Abstract][Full Text] [Related]
8. [Study of the correlation of papillary thyroid carcinoma's invasion with Ezrin, Moesin and E-Cadherin]. Tao XF; Liu C; Bai Y; Chen X Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Sep; 46(9):761-3. PubMed ID: 22177047 [TBL] [Abstract][Full Text] [Related]
9. Elevated expression of nuclear protein kinase CK2α as a poor prognosis indicator in lymph node cancerous metastases of human thyroid cancers. Guo M; Liu C; Qi FJ; Zhang XM; Ren LL; Liu YM; Meng ZC; Zhu ZT; Xiao JY Asian Pac J Cancer Prev; 2014; 15(17):7425-32. PubMed ID: 25227853 [TBL] [Abstract][Full Text] [Related]
10. E-cadherin: a differentiation marker in thyroid malignancies. Brabant G; Hoang-Vu C; Cetin Y; Dralle H; Scheumann G; Mölne J; Hansson G; Jansson S; Ericson LE; Nilsson M Cancer Res; 1993 Oct; 53(20):4987-93. PubMed ID: 8402689 [TBL] [Abstract][Full Text] [Related]
11. Expression of EphA2 and E-cadherin in colorectal cancer: correlation with cancer metastasis. Saito T; Masuda N; Miyazaki T; Kanoh K; Suzuki H; Shimura T; Asao T; Kuwano H Oncol Rep; 2004 Mar; 11(3):605-11. PubMed ID: 14767510 [TBL] [Abstract][Full Text] [Related]
12. E-cadherin adhesion molecule and syndecan-1 expression in various thyroid pathologies. Mitselou A; Ioachim E; Peschos D; Charalabopoulos K; Michael M; Agnantis NJ; Vougiouklakis T Exp Oncol; 2007 Mar; 29(1):54-60. PubMed ID: 17431390 [TBL] [Abstract][Full Text] [Related]
13. [The expression and significance of trefoil factor 3 and SDF-1/CXCR4 biological axis in papillary thyroid carcinoma]. Xue G; Huang J; Zhang H; Zhang W; Wu J; Shang X Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Jan; 28(2):108-12. PubMed ID: 24738314 [TBL] [Abstract][Full Text] [Related]
14. [An immunohistochemical study of CTHRC1,Vimentin,E-cadherin expression in papillary thyroid carcinoma]. Tang ZN; Wang YC; Liu XX; Liu QL Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Apr; 32(8):595-598. PubMed ID: 29798143 [No Abstract] [Full Text] [Related]
15. Peroxisome proliferator activated receptor gamma immunohistochemical expression in human papillary thyroid carcinoma tissues. Possible relationship to lymph node metastasis. Galusca B; Dumollard JM; Chambonniere ML; Germain N; Prades JM; Péoc'h M; Estour B Anticancer Res; 2004; 24(3b):1993-7. PubMed ID: 15274390 [TBL] [Abstract][Full Text] [Related]
16. The role of epithelial mesenchymal transition markers in thyroid carcinoma progression. Montemayor-Garcia C; Hardin H; Guo Z; Larrain C; Buehler D; Asioli S; Chen H; Lloyd RV Endocr Pathol; 2013 Dec; 24(4):206-12. PubMed ID: 24126800 [TBL] [Abstract][Full Text] [Related]
17. Histological and immunohistochemical aspects of papillary thyroid cancer. Radu TG; Mogoantă L; Busuioc CJ; Stănescu C; Grosu F Rom J Morphol Embryol; 2015; 56(2 Suppl):789-95. PubMed ID: 26429174 [TBL] [Abstract][Full Text] [Related]
18. Clinical significance of mannose-binding lectin expression in thyroid carcinoma tissues. Lu Y; Sun G; Liu G; Shi Y; Han Y; Yu F; Xiang X; Li W; Xiao H; Liu X; Li S Pathol Oncol Res; 2013 Apr; 19(2):259-66. PubMed ID: 23250731 [TBL] [Abstract][Full Text] [Related]
19. Correlation of E-cadherin, VEGF, COX-2 expression to prognostic parameters in papillary thyroid carcinoma. Erdem H; Gündogdu C; Sipal S Exp Mol Pathol; 2011 Jun; 90(3):312-7. PubMed ID: 21335003 [TBL] [Abstract][Full Text] [Related]
20. [Expression and clinical significance of Muc1, p63 protein in diffuse sclerosing variant of papillary thyroid carcinoma and conventional papillary thyroid carcinoma]. Hao Y; Jin C; Wang J Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 May; 27(9):457-61. PubMed ID: 23898609 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]